Surgalign sells Coflex product to Xtant for $17M

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million (press release)
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device
Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surger...


Join thousands of ortho pros reading exclusive OrthoStreams articles, hot startups, early trends, market insights, and the Daily Newsletter for just $1/day.
Subscribe Now—Stay Ahead!

Scroll to Top